Objectives
After participating in this educational activity, attendees should be able to:
1|Recognize the impact of mandated reporting for newborn substance exposure.
2|Define the most up-to-date mandating reporting laws
3|Describe best practices in perinatal drug testing, and how results mandated reporting
4|Present the NEW Baystate policy/guideline for 51A reporting for substance-exposed newborns
Presenter(s):
Megan R. Miller, MD
Obstetrician/Gynecologist
Assistant Professor, OB/GYN
UMass Chan - Baystate
Name | Role | Financial Relationship Disclosures | Discussion of Unlabeled/Unapproved Uses of Drugs/Devices in Presentation? |
---|---|---|---|
Megan Miller, MD, FACOG, FASAM | Speaker/Author | No relevant relationships with ineligible companies to disclose | No |
Session date:
02/04/2025 - 8:00am to 9:00am EST
Location:
Chestnut 1 A/B
759 Chestnut Street
Springfield, MA
01199
United States
See map: Google Maps
Add to calendar:
- 1.00 ACPE Contact Hours
- 1.00 AMA PRA Category 1 Credit™
- 1.00 ANCC Contact Hours
- 1.00 IPCE Credit Hour(s)